XUQ-24056-15837
3 vaccinations
6 coded responses
29 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 640 / MO
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Registered dependents
SHJ-41757-26780
Child or adolescent in my care · Female · 2022-02-06
BWP-12117-11990
Child or adolescent in my care · Female · 2022-02-06
LSJ-27533-35249
Child or adolescent in my care · Male · 2022-02-06
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-06
Survey response — 0 day, dose 1MedDRA: Ocular discomfort — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-12
- 2021-03-13
- 2021-03-20
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-26
Health check-in — 0 day, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-03
Health check-in — 7 day, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-05-02
- 2021-05-08
- 2021-06-25
-
2021-09-26
Survey response — 6 month, dose 2MedDRA: Bone pain, Fatigue — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
-
2022-01-09
Dose 3 — Pfizer-BioNTech
-
2022-02-06
Survey response — 28 day, dose 3MedDRA: Cough, Fatigue, Headache, Influenza, Pyrexia, SARS-CoV-2 test negative, Sinus pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-02-13
Survey response — 35 day, dose 3MedDRA: Asthma, Cough, Dizziness, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2022-02-13
Report sent to call center — 35 day, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-02-22
Survey response — 42 day, dose 3MedDRA: Chills, Cough, Dyspnoea, Headache, Pyrexia, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-02-25
-
2022-04-10
Survey response — 3 month, dose 3MedDRA: Asthma, COVID-19, Cough, Dyspnoea, Pre-existing disease, Secretion discharge, Sleep disorder — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-07-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2022-01-09 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-13 | Unsuccessful |
Free text
Release 5
Systemic reaction (other): Eye pressure
Release 9
Symptoms: Aches to the bone. Fatigue
Release 11
Symptoms: Bad flu-cough, sinus pain fatigue, headache, low grade fever. Tested negative twice for covid-19 since flu symptoms began.
Symptoms: Worse cough. Worse asthma. Lightheadedness
Healthcare visit (other): Family
Symptoms: Cough, low fever, headache, chills, some sneezing, frequent inhaler use for shortness breath
Symptoms: Asthma has gotten worse byfar since contracting covid in February. Still wake nightlygasoing for air at least twice a night and have to use my emergency inhaler. Lots of lingering mucus and cough frequently to attempt to express it.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Bone pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SD | Sleep disorder | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Ocular discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release